| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 21,695,000 | 21,655,000 | 22,004,000 | 20,454,000 | | Cost of Revenue |
-
| 16,929,000 | 16,974,000 | 28,533,000 | | | Gross Profit |
-
| 4,726,000 | 5,030,000 | (8,079,000) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 43,083,000 | 3,037,000 | 3,128,000 | (9,617,000) | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,518,000 | 249,000 | 234,000 | 259,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,676,000 | 1,440,000 | 1,668,000 | 1,279,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,676,000 | 1,440,000 | 1,668,000 | 1,279,000 | | Interest Expense | 137,000 | 139,000 | 131,000 | 155,000 | | Income Before Tax | 1,539,000 | 1,301,000 | 1,537,000 | 1,124,000 | | Income Tax Expense | 504,000 | 442,000 | 553,000 | 398,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,035,000 | 859,000 | 984,000 | 726,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,035,000 | 859,000 | 984,000 | 726,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,035,000 | $859,000 | $984,000 | $726,000 |
|
0.20% Nasdaq 
0.14%
Income Statement
